Lido Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,183
Closed -$243K 703
2019
Q4
$243K Sell
2,183
-2,103
-49% -$216K 0.01% 568
2019
Q3
$425K Buy
+4,286
New +$426K 0.02% 368
2019
Q2
Sell
-3,177
Closed -$350K 584
2019
Q1
$350K Buy
3,177
+82
+3% +$8.57K 0.02% 357
2018
Q4
$284K Sell
3,095
-687
-18% -$69.5K 0.03% 327
2018
Q3
$416K Buy
3,782
+324
+9% +$33.7K 0.04% 278
2018
Q2
$322K Buy
+3,458
New +$298K 0.04% 289

Other funds holding PRAH

Lido Advisors's PRAH Position: Q1 2020 in Review

Lido Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 2,183 shares — an estimated $243K sold.

Lido Advisors first reported a position in PRAH in Q2 2018 and held it in 6 quarters. The position peaked at $425K in Q3 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • Lido Advisors reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Lido Advisors sold 2,183 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $243K.
  • Lido Advisors first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 6 quarters.
  • Lido Advisors's PRA Health Sciences, Inc. position peaked at $425K in Q3 2019.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Lido Advisors's 13F filing for Q1 2020, filed 13 May 2020.